Unknown

Dataset Information

0

Taking aim at IDH in fitter patients with AML.

ABSTRACT:

SUBMITTER: Wei AH 

PROVIDER: S-EPMC9999040 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Taking aim at IDH in fitter patients with AML.

Wei Andrew H AH   Daver Naval N  

Blood 20210401 13

Similar Datasets

Unknown Taking Precise Aim at Lung Disease.
| S-EPMC6363978 | biostudies-literature
Unknown Outcomes of adult patients with newly diagnosed IDH-mutated AML treated with intensive chemotherapy and venetoclax.
| S-EPMC12510377 | biostudies-literature
Unknown Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets.
| S-EPMC3663145 | biostudies-literature
Unknown Emergent Peptides of the Antifibrotic Arsenal: Taking Aim at Myofibroblast Promoting Pathways.
| S-EPMC10452577 | biostudies-literature
Unknown Characteristics, clinical outcome, and prognostic significance of IDH mutations in AML.
| S-EPMC4612499 | biostudies-literature
Unknown Outcome of patients with IDH1/2-mutated post-myeloproliferative neoplasm AML in the era of IDH inhibitors.
| S-EPMC7656917 | biostudies-literature
Unknown Taking AIM at serious illness: implementing an access to investigational medicines expanded access program.
| S-EPMC10590908 | biostudies-literature
Unknown Prognostic significance of alterations in IDH enzyme isoforms in patients with AML treated with high-dose cytarabine and idarubicin.
| S-EPMC4060157 | biostudies-literature
Unknown HMA/VEN treatment modifications and associated outcomes in <i>IDH</i>-mutant AML.
| S-EPMC12642954 | biostudies-literature
Unknown Focal disruption of DNA methylation dynamics at enhancers in IDH-mutant AML cells.
| S-EPMC8979817 | biostudies-literature